SAM
AMPH icon

Smartleaf Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Smartleaf Asset Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.65K Hold
273
– – ﹤0.01% 2636
2026
Q1 		$5.25K Buy
273
+14
+5% +$343 ﹤0.01% 2635
2025
Q4 		$6.99K Buy
259
+52
+25% +$1.34K ﹤0.01% 2552
2025
Q3 		$5.57K Buy
207
+16
+8% +$413 ﹤0.01% 2340
2025
Q2 		$4.41K Sell
191
-376
-66% -$9.33K ﹤0.01% 2092
2025
Q1 		$16.1K Sell
567
-148
-21% -$4.73K ﹤0.01% 1716
2024
Q4 		$26.3K Buy
715
+493
+222% +$22.5K ﹤0.01% 1494
2024
Q3 		$10.7K Buy
222
+122
+122% +$5.35K ﹤0.01% 1713
2024
Q2 		$4.04K Buy
+100
New +$4.14K ﹤0.01% 1900

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Smartleaf Asset Management's AMPH Position: Q2 2026 in Review

Smartleaf Asset Management held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 273 shares worth $5.65K. The position accounts for ﹤0.01% of the portfolio, ranked #2636.

Smartleaf Asset Management first reported a position in AMPH in Q2 2024 and has held it in 9 quarters since. The position peaked at $26.3K in Q4 2024. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Smartleaf Asset Management held 273 shares of Amphastar Pharmaceuticals worth $5.65K as of Q2 2026.
  • Smartleaf Asset Management left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2636 holding.
  • Smartleaf Asset Management first reported a position in Amphastar Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Smartleaf Asset Management's Amphastar Pharmaceuticals position peaked at $26.3K in Q4 2024.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.